全球体外毒性测试市场规模、份额、趋势和成长分析报告（2026-2034年）

体外毒性测试市场预计将从 2025 年的 472.8 亿美元成长到 2034 年的 1,474.5 亿美元，2026 年至 2034 年的复合年增长率为 13.47%。

随着监管机构和製药公司积极采用替代测试方法以减少动物试验，体外毒性测试市场正经历加速成长。未来发展预计将利用晶片器官技术、3D细胞培养和高通量筛检平台，提供高度预测性和生理相关性的毒性数据。人工智慧和机器学习模型将增强终点分析、模式识别和预测性毒性分析。

与基于云端的实验室资讯管理系统 (LIMS) 和生物资讯平台集成，简化了资料收集、储存和解读流程，从而加速了药物发现和化学品安全评估中的决策。新兴的机器人操作技术、微流体技术和自动化检测平台提高了处理能力、准确性和可重复性，同时最大限度地减少了变异性。符合监管要求的体外工作流程推动了製药、化妆品和化学工业对这些技术的广泛应用。

未来的成长将受到伦理考量、严格的安全法规以及预测毒理学模型进步的驱动。透过结合高精度体外平台、人工智慧辅助分析和自动化技术，市场正在重新定义毒性测试，从而提升生命科学领域的安全性评估、营运效率和产品开发週期。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球体外毒性测试市场：依方法划分

• 市场分析、洞察与预测
• 细胞检测（活细胞、固定细胞）
• 生化分析
• In Silico
• Ek Vivo

第五章：全球体外毒性测试市场：依最终用途划分

• 市场分析、洞察与预测
• 製药业
• 化妆品和家居用品
• 学术机构和研究机构
• 诊断
• 化工
• 食品工业

第六章 全球体外毒性测试市场：依技术划分

• 市场分析、洞察与预测
• 细胞培养技术
• 高通量技术
• 分子影像
• 组学技术

第七章 全球体外毒性测试市场：依应用划分

• 市场分析、洞察与预测
• 系统毒理学
• 经皮毒性
• 内分泌干扰
• 眼毒性
• 其他用途

第八章 全球体外毒性测试市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Merck KGaA
  • Charles River
  • Bio-Rad Laboratories Inc
  • Abbott
  • Thermo Fisher Scientific Inc
  • Catalent Inc
  • GE Healthcare
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Laboratory Corporation Of America Holdings
  • Evotec
  • Creative Bioarray
  • Gentronix
  • BioIVT
  • SGS SA
  • Agilent Technologies

The In-Vitro Toxicology Testing Market size is expected to reach USD 147.45 Billion in 2034 from USD 47.28 Billion (2025) growing at a CAGR of 13.47% during 2026-2034.

The in-vitro toxicology testing market is poised for accelerated growth as regulatory agencies and pharmaceutical companies increasingly adopt alternative testing methods to reduce animal testing. Future advancements will leverage organ-on-chip technologies, 3D cell cultures, and high-throughput screening platforms to deliver predictive, physiologically relevant toxicity data. AI and machine learning models will enhance endpoint analysis, pattern recognition, and predictive toxicity profiling.

Integration with cloud-based laboratory information management systems (LIMS) and bioinformatics platforms will streamline data collection, storage, and interpretation, enabling faster decision-making in drug discovery and chemical safety assessments. Emerging robotic handling, microfluidics, and automated assay platforms will increase throughput, precision, and reproducibility while minimizing variability. Regulatory-compliant in-vitro workflows will expand adoption across pharmaceuticals, cosmetics, and chemical industries.

Future growth will be driven by ethical considerations, stringent safety regulations, and advancements in predictive toxicology models. By combining high-fidelity in-vitro platforms, AI-assisted analytics, and automation, the market will redefine toxicity testing, improving safety assessment, operational efficiency, and product development timelines across life sciences sectors.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Method

• Cellular Assay (Live Cells, Fixed Cells)
• Biochemical Assay
• In-Silico
• Ex-vivo

By End-use

• Pharmaceutical Industry
• Cosmetics & Household Products
• Academic Institutes and Research Laboratories
• Diagnostics
• Chemical Industry
• Food Industry

By Technology

• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging
• OMICS Technology

By Application

• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Ocular Toxicity
• Other Applications

COMPANIES PROFILED

• Merck KGaA, Charles River, BioRad Laboratories Inc, Abbott, Thermo Fisher Scientific Inc, Catalent Inc, GE Healthcare, Quest Diagnostics Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, Agilent Technologies
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Method
• 4.2. Cellular Assay (Live Cells, Fixed Cells) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Biochemical Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. In-Silico Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Ex-vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Pharmaceutical Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cosmetics & Household Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Academic Institutes and Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Chemical Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Food Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Cell Culture Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. High Throughput Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Molecular Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. OMICS Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Systemic Toxicology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Dermal Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Endocrine Disruption Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Ocular Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Method
  • 8.2.2 By End-use
  • 8.2.3 By Technology
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Method
  • 8.3.2 By End-use
  • 8.3.3 By Technology
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Method
  • 8.4.2 By End-use
  • 8.4.3 By Technology
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Method
  • 8.5.2 By End-use
  • 8.5.3 By Technology
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Method
  • 8.6.2 By End-use
  • 8.6.3 By Technology
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL IN-VITRO TOXICOLOGY TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Merck KGaA
  • 10.2.2 Charles River
  • 10.2.3 Bio-Rad Laboratories Inc
  • 10.2.4 Abbott
  • 10.2.5 Thermo Fisher Scientific Inc
  • 10.2.6 Catalent Inc
  • 10.2.7 GE Healthcare
  • 10.2.8 Quest Diagnostics Incorporated
  • 10.2.9 Eurofins Scientific
  • 10.2.10 Laboratory Corporation Of America Holdings
  • 10.2.11 Evotec
  • 10.2.12 Creative Bioarray
  • 10.2.13 Gentronix
  • 10.2.14 BioIVT
  • 10.2.15 SGS SA
  • 10.2.16 Agilent Technologies